Safety Announcement [01-20-2012] The U.S. Food and Drug Administration (FDA) is informing the public that testing positive for anti-JC virus (JCV) antibodies has been identified as a risk factor for progressive multifocal leukoencephalopathy (PML). PML is a rare but serious brain infection associated with use of Tysabri (natalizumab) for the treatment of multiple sclerosis (MS) or
Read More::
No Comments » 
on EMA Probes Novartis MS Pill Over DeathsHi Crissy - This is attorney Jami Haggerty. Our Facebook link is http://www.facebook.com/pages/Ennis-Ennis-PA/107176862655651. Visit our page and become a fan.
on Florida’s Rexall recalls vitamins over shellfish fearsIt took me time to learn all the comments, but I honestly loved the blog. It proved to be very
on Roche Faces First Trial of Claims Over Raptiva InfectionsVivian this is David Ennis and thank your for your reply. We have our own facebook, twitter and youtube page.
on J&J Pays $158M To Settle Risperdal Lawsuit In TexasRisperal reproached. Same saga here as Eli Lilly Zyprexa. Johnson and Johnson is a trusted brand we associate with babies.
on Roche Faces First Trial of Claims Over Raptiva Infectionsi love your blog, i have it in my rss reader and always like new things coming up from it.
